TRANSPLANTATION PROCEEDINGS
GUIDELINES FOR THE PREPARATION
AND SUBMISSION OF MANUSCRIPTS ASSOCIATED WITH A CONGRESS, SYMPOSIA OR MEETING
Transplantation Proceedings is a peer-reviewed
journal. Contributions are only accepted
for publication that add substantial information to
the already published literature.
Transplantation Proceedings considers
manuscripts for publication in association with congresses, symposia or
meetings. They must be submitted at the
time of the meeting to authorized Transplantation Proceedings
representatives. At that time pages are
counted, and a tracking number is assigned to the manuscript. Manuscript page charges are based on the
number of typed, submitted pages, NOT on the number of printed pages. Authors are responsible for charges for all
pages except those granted based upon written permission of the
organizers. If the manuscript is
accepted for publication, authors will be notified of any complimentary pages
and be invoiced by the publisher, Elsevier, at US$99.95 each, payable upon invoice.
I.
Authorship: This journal adheres to the Uniform
Requirements set by the International Committee of Medical Journal Editors (http://www.icmje.org) for authorship. Authors submitting a manuscript do so on the understanding
that the work has neither been published nor is being considered for
publication elsewhere. The manuscript
must have been read and approved by all authors.
II.
Statement Regarding
Duplicate Publication: Legitimate
uses of the journal in addition to comprehensive studies include publications
of preliminary reports, such as an initial analysis of a limited unique study
or an assessment of early experimental findings of urgent interest. Duplicate publication is the verbatim
inclusion of a subset of data derived from a much larger, already published or
recently submitted analysis. Duplicate
publication is wasteful of journal space and reviewers’ efforts and may be a
violation of copyright laws. Transplantation
Proceedings has recently resolved to implement a series of sanctions
should duplicate publications be discovered.
Authors must agree that their manuscript has not been submitted or
published in any other journal, including Transplantation Proceedings, and no
parts of the manuscript are duplicated.
III.
Basic Requirements
for all submissions: Specific information
regarding guidelines for submission are listed below,
which must be strictly followed to avoid delay in the review or rejection of
the manuscript. Instructions for Case Reports are listed under item V: “Case Reports”.
1.
All
submissions require an Abstract (maximum 300 words)
2.
Manuscripts (including the Abstract and References)
must be:
a. Typed in English (the submission
must be read and corrected by an English-speaking person prior to submission if
English is not the first language of the authors)
b. Contain at least 3 fully typed
pages of text with a Table or Figure to describe the data
c. DOUBLE-SPACED
d. Sized for LETTER and not
A4
e. Typed with an 11 point font
f. Set up on a single page, not in
columns
g. All manuscript pages must be
numbered
h. Accompanied by a CD, programmed
for PC only – containing all components of the submission
i. All references must be fully
cited to include at least the first three authors followed by the words “et
al”. The full article title must be
included followed by the journal name, year, volume and page number
3.
Authorship and Conflict of
Interest Form (ACIS): Every
manuscript submitted to Transplantation Proceedings must
contain two typed, completed ACIS forms, each signed by the corresponding
author. The Corresponding Author is
therefore acknowledging that EVERY author listed on the manuscript has meet criteria for authorship. This from must accompany the manuscript UPON
submission, and must be stapled to the manuscript prior to submission. Manuscripts without a completed form will not
be considered for publication.
4.
Use of Abbreviations: Authors must limit the use of
abbreviations, using only standard ones when necessary. No abbreviations should be used in the Title
except if they are spelled out then followed by the abbreviation in
parentheses. Abbreviations used for the
first time in the Title, or in the Abstract, or in the Text, or in the Tables,
or in the Figures must first be spelled out then followed by the abbreviation
in parentheses. This practice should be
adhered to for each section; citing an abbreviation in the Title is not
sufficient for each of the remaining parts of the manuscript.
IV.
Manuscript components:
A.
ACIS
Form
The ACIS Form must be
completed and stapled to each copy of the manuscript. Any manuscript without this form will not be
considered and will be returned.
B.
Title
Page: The title
page should carry the following information:
1.
Article title. Concise titles are
easier to read than long convoluted ones. Titles that are too short may,
however, lack important information, such as study design which is particularly
important in identifying randomized, controlled trials. Authors should include
all information in the title that will make electronic retrieval of the article
both sensitive and specific. Authors must state in the Title if the article is
a Case Report. If the manuscript is an
animal study, authors must state the species WITHIN the Title.
2.
Authors must not use abbreviations (without fully
stipulating the subject) in the Title
3.
Authors’ names, institutional affiliations and email
addresses of each author.
4.
The name of the department(s) and institution(s) to
which the work should be attributed.
5.
Contact information for the corresponding author must
include the name, mailing address, telephone, fax number, and e-mail address of
the author responsible for correspondence about the manuscript. The
“corresponding author” may or may not be the “guarantor” for the integrity of
the study. The corresponding author should indicate clearly whether his or her
e-mail address can be published.
6.
The name, email address and physical address of the
author to whom requests for reprints should be
addressed; this person is generally the author who is responsible for the
integrity of the work as a whole.
7.
Source(s) of support in the form of grants, equipment,
drugs, or all of these.
8.
The number of Figures and Tables. It is difficult for
the editorial staff and the reviewers to determine whether Figures and Tables
that should have accompanied a manuscript were actually included unless the
numbers of each of them are noted on the title page.
C. Abstract:
The abstract should follow the Title Page. It should begin with the word
“Abstract”; on the next line, the title of the manuscript. The Abstract should provide the context or
background for the study and should state the study’s purpose, basic procedures
(selection of study subjects or laboratory animals, observational and analytical
methods), main findings (giving specific effect sizes and their statistical
significance, if possible), and principle major conclusions. It should
emphasize new and important aspects of the study or observations.
Authors need to carefully and
accurately reflect the content of the article in the abstract since this is the
only substantive portion of the article indexed in many electronic databases,
and the only portion which may be read.
D. Introduction: Provide a context or background
for the study, that is, the nature of the problem and its significance. State
the specific purpose or research objective of, or hypothesis tested by, the
study or observation; the research objective is often more sharply focused when
stated as a question. Both the main and secondary objectives should be clear,
and any pre-specified subgroup analyses should be described. Provide only
directly pertinent references; do not include data or conclusions from the work
being reported.
E.
Methods: The Methods section
should include only information that was available at the time the plan or
protocol for the study was being written; all information obtained during the
study belongs in the Results section.
When reporting on human subjects, indicate whether the procedures were
approved by your Ethics Committee for Human Experimentation or Institutional
Review Board, and are in accordance with the Helsinki Declaration of 1975 (as
revised in 1983). For the appropriate
studies indicate any or Animal Care and Use Committee protocol numbers as
warranted by the experimental design.
1.
Selection
and Description of Participants: Describe
your selection of the observational or experimental participants (patients or
laboratory animals, including controls) clearly, including
eligibility/exclusion criteria and a description of the source population.
Because the relevance of such variables as age and gender to the object of the
research is not always clear, authors should explain their use when they are
included in a study report: For example,
authors should explain why only participants of certain ages were included or
why women were excluded. The guiding principle should be clarity about how and
why a study was performed in a particular way.
Authors must define measurements of variables and justify their
relevance.
2. Technical
information: Identify
the methods, apparatus (give the manufacturer’s name, city and country in
parentheses), and procedures in sufficient detail to allow others to reproduce
the results. Give references to established methods, including statistical
methods (see below); provide references and brief descriptions for methods that
have been published but are not well-known; describe new or substantially
modified methods, showing the reasons for the adaptations, and evaluate their
limitations. Identify precisely all drugs and chemicals used, including generic
name(s), dose(s), and route(s) of administration.
Authors submitting review manuscripts should include a
section describing the methods used for locating, selecting, extracting, and
synthesizing data. These methods should also be summarized in the abstract.
3.
Statistical
Techniques: Describe
statistical methods with enough detail to enable a knowledgeable reader with
access to the original data to verify the reported results. When possible,
quantify findings and present them with appropriate indicators of measurement
error or uncertainty (such as confidence intervals). Avoid relying solely on
statistical hypothesis testing, such as P values, which fail to convey
important information about the effects of sample size. References for the
design of the study and statistical methods should be to standard works when
possible (with pages stated). Define statistical terms, abbreviations, and most
symbols. Specify the computer software.
F. Results:
Present your results in logical sequence in the text,
Tables, and illustrations, starting with the main or most important findings.
Do not repeat all of the data enumerated in the Tables or illustrations in the
text; emphasize or summarize only the most important observations. Extra or
supplementary materials and technical details can be placed in an appendix
which is accessible but does not interrupt the flow of the text, or they can be
published solely in the electronic version of the journal. When data are
summarized in the Results section, give numeric results not only as derivatives
(for example, percentages) but also as the absolute numbers from which the
derivatives were calculated; specify the statistical methods used to analyze
them. Restrict Tables and Figures to those needed to explain the argument of
the paper and to assess supporting data. Use graphs as an alternative to Tables
with many entries; do not duplicate data in Figures and Tables. Avoid nontechnical uses of technical terms in statistics, such as
“random” (which implies a randomizing device), “normal,” “significant,”
“correlations,” and “sample.”
In general clinical data
require multivariate analysis. Where
scientifically appropriate, analyses of the data by such variables as age and
gender should be included.
G. Discussion:
Emphasize the new, important aspects of the study and the conclusions therefrom. Do not repeat in detail data or other
information given in the Introduction or the Results section. For experimental
studies, it is useful to begin the discussion by summarizing briefly the main
findings, and then by exploring possible mechanisms or explanations for these
observations. Compare and contrast the
results with other relevant studies, state the limitations of the study, and
explore the implications of the findings for future research and for clinical
practice. Link the conclusions with the goals of the study, but avoid
unqualified statements and conclusions that are not adequately supported by the
data. In particular, avoid making statements on cost benefits unless the
manuscript includes the appropriate analyses of economic data. Avoid claiming
priority or alluding to work that has not been completed. State new hypotheses when
warranted, but label them clearly as such.
H. References:
References should be numbered consecutively in the order in which they
are first mentioned in the text. References must contain the first three
authors followed by the words “et al”.
The full article cited must be included, followed by the journal name,
year, volume and page numbers.
Authors are responsible for
checking that none of the references cite retracted articles except in the
context of referring to the retraction. For articles published in journals
indexed in MEDLINE, the ICMJE considers PubMed the authoritative source for information about
retractions. Authors can identify retracted articles in MEDLINE by using the
following search term, where pt in square brackets stands for publication type:
Retracted publication [pt] in PubMed.
I. Tables:
Tables capture information concisely and display it efficiently; thereby
frequently making it possible to reduce the length of the text.
1. Type or print each Table with double spacing
on a separate sheet of paper. Number Tables consecutively in the order of their
first citation in the text and supply a brief title for each. Do not use
internal horizontal or vertical lines. Give each column a short or an
abbreviated heading.
2. Authors should place explanatory matter in
footnotes, not in the heading. Explain all nonstandard abbreviations in
footnotes, and use the following symbols, in sequence: *,†,‡,§,||,¶,**,††,‡‡
3. Identify statistical measures of variations,
such as standard deviations or standard errors of the mean.
4. Be sure that each
Table is cited in the text.
5. If you use data from another published or
unpublished source, obtain permission and acknowledge that source fully.
J. Illustrations (Figures): Please visit the publisher’s
website http://www.elsevier.com/locate/authorartwork
for detailed instructions. Figures should
be either professionally drawn and photographed, or submitted as
photographic-quality digital prints. In addition to requiring a version of the
Figures suitable for printing, we ask authors for electronic files of Figures
in a format (for example, JPEG or GIF) that will produce high-quality images in
the Web version of the journal; authors should review the images of such files
on a computer screen before submitting them to be sure they meet their own
quality standards.
1.
For x-ray films, scans, and other diagnostic images,
as well as pictures of pathology specimens or photomicrographs, send sharp,
glossy, black-and-white or color photographic prints, usually 127 x 173 mm (5 x
7 inches). Letters, numbers, and symbols on Figures should therefore be clear
and consistent throughout, and large enough to remain legible when the Figure
is reduced for publication. Figures should be made as self-explanatory as
possible. Titles and detailed explanations belong in the legends--not on the
illustrations themselves.
2.
Photomicrographs should have internal scale markers.
Symbols, arrows, or letters used in photomicrographs should contrast with the
background. Photographs of potentially identifiable people must be accompanied
by written permission to use the photograph.
3.
Figures should be numbered consecutively according to
the order in which they have been cited in the text. If a Figure has been
published previously, acknowledge the original source and submit written
permission from the copyright holder to reproduce the Figure. Permission is
required irrespective of authorship or publisher except for documents in the
public domain.
4. For illustrations in color, authors must
agree to the additional charge of US$650 for the first two color reproductions
on a page and US$100 for each color reproduction thereafter.
K. Legends
for Illustrations (Figures): Type or print out
legends for illustrations using double spacing, starting on a separate page,
with Arabic numerals corresponding to the illustrations. When symbols, arrows,
numbers, or letters are used to identify parts of the illustrations, identify
and explain each one clearly in the legend. Explain the internal scale and
identify the method of staining in photomicrographs.
L. Units
of Measurement: Measurements of
length, height, weight, and volume should be reported in metric units (meter,
kilogram, or liter) or their decimal multiples.
Temperatures should be in
degrees Celsius. Blood pressures should be in millimeters of mercury
V.
Case Reports: Each Case Report must conform to the standards
specified under item III: “Basic requirements for all submissions”
1.
Case Reports should include an Abstract, an
Introduction, The Case Report, a Discussion, References and Tables/Figures
2.
The Case being reported should represent a unique
clinical experience; the report must explicitly state the reason(s) that the
authors believe the case to be unique
3.
Title: The
Title must include the statement “Case Report”
4.
Abstract: This
section, in addition to describing the patient(s), should emphasize the unique
features
5.
Introduction:
This section must include previous descriptions of similar cases
6.
Case Report:
The Report must include all relevant clinical data supplemented with
Tables and/or Figures. The unique
aspects of the case must be objectively documented with data
7.
Discussion:
This section must present the implications of the unique features of the
case
8.
References:
Similar cases must be Referenced